Machine-learning drug development company Insitro has inked three agreements with Eli Lilly for new medicines for metabolic diseases. But the deal is a little different
Amid Hurricane Helene shuttering a major IV solution manufacturing plant and Hurricane Milton now barreling toward other IV manufacturing facilities in central Florida, the American
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Today’s item on bacterial outbreaks linked to
From its founding days, Carequality knew that overseeing the flow of sensitive patient information in U.S. health care would be a tricky business. But the
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. In a new study in JAMA Oncology,
In the raging debate about how to regulate artificial intelligence in health care, “there seem to be two camps that are emerging,” says Raj Ratwani,
Generate:Biomedicines, a Flagship Pioneering company using artificial intelligence to create new medicines, announced today that it has struck a deal with Novartis to develop an
If you’re a health care worker who vibes with this Tiktok, have I got a newsletter for you: STAT’s Health Care, Inc. by Bob Herman
Francis Collins’ reputation precedes him: A scientist’s scientist, he obtained a Ph.D. in physical chemistry before going to medical school and subsequently becoming a molecular
WELLESLEY, Mass. — Amid heated discussions on how artificial intelligence should be regulated and who should be involved in health care AI governance, the U.S.